about
Cellular Therapies in Systemic Sclerosis: Recent ProgressEffect of menopause on the modified Rodnan skin score in systemic sclerosis.Canonical Wnt signaling induces skin fibrosis and subcutaneous lipoatrophy: a novel mouse model for scleroderma?Vascular involvement in systemic sclerosis (scleroderma).Pathogenesis of Systemic Sclerosis.CD109, a TGF-β co-receptor, attenuates extracellular matrix production in scleroderma skin fibroblasts.Dose-escalation of human anti-interferon-α receptor monoclonal antibody MEDI-546 in subjects with systemic sclerosis: a phase 1, multicenter, open label study.
P2860
Q28080323-7A53EEC8-37EF-4145-A47E-83CF6D9E7F6BQ33892434-ECA35511-809F-4A06-913E-4B528D77A7D3Q35072458-C831C1A3-862C-4A6D-BA7A-E0300AFBFC27Q35557424-592A7277-8F03-472F-9838-2D51748FD81FQ35693212-FB8C2D75-F664-4C33-8EB6-81A9521B5160Q36246124-000C8C1B-D0CB-41A2-AC7D-1753D0D66D7CQ37690732-5E4F9544-EF33-4533-AC55-C17ACA903AB4
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Pharmacotherapy of systemic sclerosis
@ast
Pharmacotherapy of systemic sclerosis
@en
Pharmacotherapy of systemic sclerosis
@nl
type
label
Pharmacotherapy of systemic sclerosis
@ast
Pharmacotherapy of systemic sclerosis
@en
Pharmacotherapy of systemic sclerosis
@nl
prefLabel
Pharmacotherapy of systemic sclerosis
@ast
Pharmacotherapy of systemic sclerosis
@en
Pharmacotherapy of systemic sclerosis
@nl
P2093
P2860
P1476
Pharmacotherapy of systemic sclerosis
@en
P2093
Arnold E Postlethwaite
Swapna Kodura
Syed H Raza
Titilola Akhigbe
P2860
P304
P356
10.1517/14656561003592177
P407
P577
2010-04-01T00:00:00Z